Ergomed Group, founded in 1997, offers custom-made clinical solutions for every stage of development from proof-of-concept to late-stage programs. With a global footprint covering 100+ countries, Ergomed provides specialized services to the pharmaceutical industry, including clinical development, trial management, and pharmacovigilance. The company has a focus on oncology, rare diseases, neurology/CNS, allergy/respiratory, and other therapeutic areas, offering a broad range of specialized services such as project management, regulatory affairs, patient-centric solutions, biometrics, medical writing, and quality assurance. Ergomed has a strong track record of providing clinical services to a diverse range of clients, from top pharmaceutical organizations to mid-sized drug development companies.